Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study.
Feldman GJ, Sousa AR, Lipson DA, Tombs L, Barnes N, Riley JH, Patel S, Naya I, Compton C, Alcázar Navarrete B. Feldman GJ, et al. Among authors: alcazar navarrete b. Adv Ther. 2017 Nov;34(11):2518-2533. doi: 10.1007/s12325-017-0626-4. Epub 2017 Nov 1. Adv Ther. 2017. PMID: 29094315 Free PMC article. Clinical Trial.
Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population.
Almonacid-Sánchez C, Cosío BG, Trisán-Alonso A, Callejas-González FJ, Cisneros C, Martínez-Moragón E, Plaza Moral V, Vera E, Soto-Campos JG, Martínez-Rivera C, Alcazar-Navarrete B, Urrutia Landa I, García-Rivero JL, Padilla Galo A, Álvarez-Gutierrez F, Ramos-González J, Carretero-Gracia JÁ, Lluch I, Puente L, Andujar-Espinosa R, Pérez-de-Llano L. Almonacid-Sánchez C, et al. Among authors: alcazar navarrete b. Arch Bronconeumol. 2023 Dec;59(12):842-845. doi: 10.1016/j.arbres.2023.08.017. Epub 2023 Oct 5. Arch Bronconeumol. 2023. PMID: 37865605 English, Spanish. No abstract available.
Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment.
Turégano-Yedro M, Trillo-Calvo E, Navarro I Ros F, Maya-Viejo JD, González Villaescusa C, Echave Sustaeta JM, Doña E, Alcázar Navarrete B. Turégano-Yedro M, et al. Among authors: alcazar navarrete b. Int J Chron Obstruct Pulmon Dis. 2023 Dec 4;18:2887-2893. doi: 10.2147/COPD.S431829. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 38059011 Free PMC article. Review.
Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit.
Calle Rubio M, Miravitlles M, López-Campos JL, Alcázar Navarrete B, Soler Cataluña JJ, Fuentes Ferrer ME, Rodríguez Hermosa JL. Calle Rubio M, et al. Among authors: alcazar navarrete b. Arch Bronconeumol. 2023 Nov;59(11):725-735. doi: 10.1016/j.arbres.2023.07.015. Epub 2023 Jul 22. Arch Bronconeumol. 2023. PMID: 37563018 English, Spanish.
Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Driessen MT, Whalen J, Seewoodharry Buguth B, Vallejo-Aparicio LA, Naya IP, Asukai Y, Alcázar-Navarrete B, Miravitlles M, García-Río F, Risebrough NA. Driessen MT, et al. Among authors: alcazar navarrete b. Respir Res. 2018 Nov 20;19(1):224. doi: 10.1186/s12931-018-0916-7. Respir Res. 2018. PMID: 30458866 Free PMC article. Clinical Trial.
Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Driessen MT, Whalen J, Buguth BS, Vallejo-Aparicio LA, Naya IP, Asukai Y, Alcázar-Navarrete B, Miravitlles M, García-Río F, Risebrough NA. Driessen MT, et al. Among authors: alcazar navarrete b. Respir Res. 2019 Jan 28;20(1):18. doi: 10.1186/s12931-019-0985-2. Respir Res. 2019. PMID: 30691468 Free PMC article.
The Future of Triple Therapy in chronic obstructive pulmonary disease.
Alcázar-Navarrete B, Castellano Miñán F, Romero Palacios PJ. Alcázar-Navarrete B, et al. Arch Bronconeumol (Engl Ed). 2018 Feb;54(2):63-64. doi: 10.1016/j.arbres.2017.06.019. Epub 2017 Jul 29. Arch Bronconeumol (Engl Ed). 2018. PMID: 28760570 English, Spanish. No abstract available.
A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.
Miravitlles M, Cosío BG, Arnedillo A, Calle M, Alcázar-Navarrete B, González C, Esteban C, Trigueros JA, Rodríguez González-Moro JM, Quintano Jiménez JA, Baloira A. Miravitlles M, et al. Among authors: alcazar navarrete b. Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y. Respir Res. 2017. PMID: 29183382 Free PMC article. Review.
68 results